The use of systemic and topical fluoroquinolones

John S. Bradley, Mary Anne Jackson, Michael T. Brady, Henry H. Bernstein, Carrie L. Byington, Kathryn M. Edwards, Margaret C. Fisher, Mary P. Glode, Harry L. Keyserling, David W. Kimberlin, Yvonne A. Maldonado, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Abstract

Appropriate prescribing practices for fluoroquinolones are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children becomes better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Although fluoroquinolones are reasonably safe in children, clinicians should be aware of the specific adverse reactions. Use of fluoroquinolones in children should continue to be limited to treatment of infections for which no safe and effective alternative exists.

Original languageEnglish (US)
Pages (from-to)e1034-e1045
JournalPediatrics
Volume128
Issue number4
DOIs
StatePublished - Oct 2011

Keywords

  • Fluoroquinolones
  • Infectious diseases
  • Pediatrics
  • Systemic therapy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'The use of systemic and topical fluoroquinolones'. Together they form a unique fingerprint.

Cite this